日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism

2q染色体间区单核苷酸多态性与组织因子途径抑制剂血浆水平和静脉血栓栓塞相关

Dennis, J; Truong, V; Aïssi, D; Medina-Rivera, A; Blankenberg, S; Germain, M; Lemire, M; Antounians, L; Civelek, M; Schnabel, R; Wells, P; Wilson, M D; Morange, P-E; Trégouët, D-A; Gagnon, F

Is there still room for additional common susceptibility alleles for venous thromboembolism?

是否还有其他常见的静脉血栓栓塞易感基因?

Trégouët, D A; Delluc, A; Roche, A; Derbois, C; Olaso, R; Germain, M; de Andrade, M; Tang, W; Chasman, D I; van Hylckama Vlieg, A; Reitsma, P H; Kabrhel, C; Smith, N; Morange, P E

Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism

Thrombo inCode(一种用于评估静脉血栓栓塞风险的临床遗传学功能)的经济分析

Rubio-Terrés, C; Soria, J M; Morange, P E; Souto, J C; Suchon, P; Mateo, J; Saut, N; Rubio-Rodríguez, D; Sala, J; Gracia, A; Pich, S; Salas, E

Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies

F3(组织因子)基因变异与静脉血栓形成风险:八项研究的荟萃分析

Smith, N L; Heit, J A; Tang, W; Teichert, M; Chasman, D I; Morange, P-E

Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.

系统性趋化因子水平、冠心病和缺血性中风事件:PRIME 研究

Canouï-Poitrine F, Luc G, Mallat Z, Machez E, Bingham A, Ferrieres J, Ruidavets J-B, Montaye M, Yarnell J, Haas B, Arveiler D, Morange P, Kee F, Evans A, Amouyel P, Ducimetiere P, Empana J-P

Juvenile temporal arteritis and activated protein C resistance

幼年颞动脉炎和活化蛋白C抵抗

Granel, B; Serratrice, J; Ene, N; Morange, P E; Disdier, P; Weiller, P-J